{"id":"W4386836949","doi":"10.1186/s13075-023-03128-1","title":"Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study","year":2023,"lang":"en","type":"article","venue":"Arthritis Research & Therapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Arthritis Society; University of Toronto; University Health Network","funders":"UCB Pharma; Celgene; Gilead Sciences; Eisai; Sanofi; Chugai Pharmaceutical; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Ankylosing spondylitis; Internal medicine; Placebo; Adverse effect; Rheumatology; BASFI; BASDAI; Rheumatoid arthritis; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004837445,0.001020035,0.002129949,0.0004273916,0.0004981076,0.001185831,0.0005622113,0.001085314,0.001170393],"category_scores_gemma":[0.002337503,0.0003400119,0.001974668,0.0005348608,0.000652117,0.0008547621,0.0003648656,0.00221344,0.0003197531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009367442,"about_ca_system_score_gemma":0.001171668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008694412,"about_ca_topic_score_gemma":0.001704581,"domain_scores_codex":[0.9987078,0.0006024707,0.0001303551,0.0001505197,0.0001926032,0.0002162368],"domain_scores_gemma":[0.996503,0.0006814581,0.001335711,0.0002777334,0.0003951795,0.0008069507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7988525,0.02377805,0.05873305,0.001075424,0.004760937,0.0003315356,0.0003745287,0.001687468,0.01512506,0.00009131919,0.002381634,0.09280842],"study_design_scores_gemma":[0.3026381,0.4728033,0.2091008,0.0001497174,0.004251526,0.0009068765,0.0001904155,0.002043938,0.004832832,0.0001274036,0.002862868,0.00009233918],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994891,0.002956141,0.0002094075,0.0001109927,0.0000356143,0.0004897008,0.0007628264,0.00002069551,0.000523448],"genre_scores_gemma":[0.9957743,0.001014252,0.0003704583,0.0002487123,0.00009486423,0.0003473612,0.001811879,0.000006750244,0.0003313981],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004837445,"threshold_uncertainty_score":0.02558315,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1138991202921506,"score_gpt":0.4035689931621553,"score_spread":0.2896698728700047,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}